Login
$OCGN
$0.77 -$0.06 (7.01%) Live

$OCGN 8-K/A SEC Filings

Filed On Filing
07 Feb 2025 8-K/A: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more

CERTAIN INFORMATION IN THIS DOCUMENT, MARKED BY [***], HAS BEEN EXCLUDED PURSUANT TO REGULATION S-K, ITEM 601(b)(10)(iv). SUCH EXCLUDED INFORMATION IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

07 Oct 2019 8-K/A: Other Events

See accompanying notes to condensed consolidated financial statements.

13 May 2019 8-K/A: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement

On May 8, 2019, Histogenics Corporation (the “Company”) entered into an asset purchase agreement with Medavate Corp., a Colorado corporation (the “Asset Purchase Agreement”), pursuant to which the Company has agreed to sell substantially...

03 Jan 2019 8-K/A: Notice of Delisting or Failure to Satisfy a Listing Rule

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support